Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy ; volume:13 ; number:1 ; day:3 ; month:4 ; year:2024 ; pages:1-34 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (3.4.2024), 1-34, 12.2024
- Creator
-
Shao, Weihuan
Yao, Yiran
Yang, Ludi
Li, Xiaoran
Ge, Tongxin
Zheng, Yue
Zhu, Qiuyi
Ge, Shengfang
Gu, Xiang
Jia, Renbing
Song, Xin
Zhuang, Ai
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00504-8
- URN
-
urn:nbn:de:101:1-2406190935229.300319991259
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shao, Weihuan
- Yao, Yiran
- Yang, Ludi
- Li, Xiaoran
- Ge, Tongxin
- Zheng, Yue
- Zhu, Qiuyi
- Ge, Shengfang
- Gu, Xiang
- Jia, Renbing
- Song, Xin
- Zhuang, Ai
- SpringerLink (Online service)
Other Objects (12)
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy against ovarian cancer
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy against ovarian cancer
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy against ovarian cancer
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy